20.08.2018 11:12:01

DGAP-CMS: CompuGroup Medical SE: Release of a capital market information

DGAP Post-admission Duties announcement: CompuGroup Medical SE / Share Buyback
CompuGroup Medical SE: Release of a capital market information

20.08.2018 / 11:12
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 5th Interim Announcement

CompuGroup Medical SE / Share Buyback

Koblenz, August 20, 2018

CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 5th Interim Announcement

In the period from August 13, 2018, up to and including August 17, 2018, CompuGroup Medical SE has bought back a total of 38,419 shares of CompuGroup Medical SE within the framework of the share buyback program. In the announcement of July 13, 2018, pursuant to Art. 2 para. 1 of the Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 (MAR) it was communicated that the repurchase of treasury shares would commence on July 16, 2018.

The overall volume of the shares bought back daily in the period from August 13, 2018, up to and including August 17, 2018, and the daily volumeweighted average stock market prices of the shares are as follows:

Date Overall volume of Volume-weighted average stock
shares bought back market price
(number) (EUR, excluding ancillary
costs of purchase, rounded to
four places according to
commercial practice)
August 13, 2018 7,748 49.1787
August 14, 2018 8,940 49.5308
August 15, 2018 9,800 49.1228
August 16, 2018 5,000 48.8344
August 17, 2018 6,931 48.6047
In total: 38,419 49.0980

The total number of shares which have been bought back so far by CompuGroup Medical SE since July 16, 2018, up to and including August 17, 2018, within the framework of the share buyback program thus amounts to 195,823 no-par value shares.

Further information pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 is available online under https://www.cgm.com/sbb.

The purchase of the shares of CompuGroup Medical SE was carried out by a bank assigned by CompuGroup Medical SE and exclusively via the Frankfurt Stock Exchange (Xetra trading).

Koblenz, August 20, 2018

The Management Board

CompuGroup Medical SE
Investor Relations
Maria Trost 21
56070 Koblenz, Germany
T: 49 (0) 261 8000-6200
F: 49 (0) 261 8000-3200



20.08.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: CompuGroup Medical SE
Maria Trost 21
56070 Koblenz
Germany
Internet: www.cgm.com

 
End of News DGAP News Service

715559  20.08.2018 

fncls.ssp?fn=show_t_gif&application_id=715559&application_name=news&site_id=smarthouse

Analysen zu CompuGroup Medical SEmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!